Does liver-intestine significantly degrade circulating endogenous substance P in man?

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Does liver-intestine significantly degrade circulating endogenous substance P in man? / Henriksen, Jens Henrik Sahl; Schaffalitzky de Muckadell, O B; Bülow, J B.

In: Scandinavian Journal of Gastroenterology, Vol. 21, No. 3, 1986, p. 300-4.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Henriksen, JHS, Schaffalitzky de Muckadell, OB & Bülow, JB 1986, 'Does liver-intestine significantly degrade circulating endogenous substance P in man?', Scandinavian Journal of Gastroenterology, vol. 21, no. 3, pp. 300-4.

APA

Henriksen, J. H. S., Schaffalitzky de Muckadell, O. B., & Bülow, J. B. (1986). Does liver-intestine significantly degrade circulating endogenous substance P in man? Scandinavian Journal of Gastroenterology, 21(3), 300-4.

Vancouver

Henriksen JHS, Schaffalitzky de Muckadell OB, Bülow JB. Does liver-intestine significantly degrade circulating endogenous substance P in man? Scandinavian Journal of Gastroenterology. 1986;21(3):300-4.

Author

Henriksen, Jens Henrik Sahl ; Schaffalitzky de Muckadell, O B ; Bülow, J B. / Does liver-intestine significantly degrade circulating endogenous substance P in man?. In: Scandinavian Journal of Gastroenterology. 1986 ; Vol. 21, No. 3. pp. 300-4.

Bibtex

@article{cd8fe3c038cb11dfad7f000ea68e967b,
title = "Does liver-intestine significantly degrade circulating endogenous substance P in man?",
abstract = "Elevated concentrations of circulating substance P in patients with liver insufficiency have been ascribed to decreased hepatic degradation. To establish a possible biodegradation of the peptide in liver-intestine and kidneys, the concentration of endogenous immunoreactive substance P was determined in various vascular beds during a right-sided catheterization in 13 subjects without liver insufficiency. All subjects had normal values of circulating substance P, and no significant difference was found between systemic plasma and hepatic venous or renal venous concentrations of substance P. The results indicate that degradation of circulating endogenous substance P in man is not confined to liver-intestine or kidney but may take place in many tissues.",
author = "Henriksen, {Jens Henrik Sahl} and {Schaffalitzky de Muckadell}, {O B} and B{\"u}low, {J B}",
note = "Keywords: Adult; Aged; Female; Humans; Intestines; Liver; Male; Middle Aged; Substance P; Veins",
year = "1986",
language = "English",
volume = "21",
pages = "300--4",
journal = "Scandinavian Journal of Gastroenterology",
issn = "0036-5521",
publisher = "Taylor & Francis",
number = "3",

}

RIS

TY - JOUR

T1 - Does liver-intestine significantly degrade circulating endogenous substance P in man?

AU - Henriksen, Jens Henrik Sahl

AU - Schaffalitzky de Muckadell, O B

AU - Bülow, J B

N1 - Keywords: Adult; Aged; Female; Humans; Intestines; Liver; Male; Middle Aged; Substance P; Veins

PY - 1986

Y1 - 1986

N2 - Elevated concentrations of circulating substance P in patients with liver insufficiency have been ascribed to decreased hepatic degradation. To establish a possible biodegradation of the peptide in liver-intestine and kidneys, the concentration of endogenous immunoreactive substance P was determined in various vascular beds during a right-sided catheterization in 13 subjects without liver insufficiency. All subjects had normal values of circulating substance P, and no significant difference was found between systemic plasma and hepatic venous or renal venous concentrations of substance P. The results indicate that degradation of circulating endogenous substance P in man is not confined to liver-intestine or kidney but may take place in many tissues.

AB - Elevated concentrations of circulating substance P in patients with liver insufficiency have been ascribed to decreased hepatic degradation. To establish a possible biodegradation of the peptide in liver-intestine and kidneys, the concentration of endogenous immunoreactive substance P was determined in various vascular beds during a right-sided catheterization in 13 subjects without liver insufficiency. All subjects had normal values of circulating substance P, and no significant difference was found between systemic plasma and hepatic venous or renal venous concentrations of substance P. The results indicate that degradation of circulating endogenous substance P in man is not confined to liver-intestine or kidney but may take place in many tissues.

M3 - Journal article

C2 - 2424079

VL - 21

SP - 300

EP - 304

JO - Scandinavian Journal of Gastroenterology

JF - Scandinavian Journal of Gastroenterology

SN - 0036-5521

IS - 3

ER -

ID: 18838254